Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2022 Earnings Conference Call August 4, 2022 8:00 AM ET
Company Participants
Holly Manning - Senior Director, Investor Relations
Jackie Fouse - Chief Executive Officer
Sarah Gheuens - Chief Medical Officer and Head of R&D
Richa Poddar - Chief Commercial Officer
Jonathan Biller - Chief Financial Officer and Head of Corporate Affairs
Conference Call Participants
Marc Frahm - Cowen
Andrew Berens - SVB Leerink
Danielle Brill - Raymond James
Operator
Good morning and welcome to Agios Second Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the call. Please be advised that this call is being recorded at Agios' request.
I would now like to turn the conference over to Holly Manning, Senior Director of Investor Relations. Please go ahead.
Holly Manning
Thank you, operator. Good morning, everyone, and welcome to Agios' second quarter 2022 conference call. You can access slides for today's call by going to the Investors Section of our website, agios.com.
With me on the call today with prepared remarks are Dr. Jackie Fouse, our Chief Executive Officer; Dr. Sarah Gheuens, our Chief Medical Officer and Head of Research and Development; Richard Poddar, our Chief Commercial Officer; and Jonathan Biller, our Chief Financial Officer and Head of Corporate Affairs.
Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those set forth in our most recent filings with the SEC and any other future filings that we may make with the SEC.
With that, I will turn
- Read more current AGIO analysis and news
- View all earnings call transcripts